scispace - formally typeset
P

Prakash Narayana Reddy

Researcher at Vignan University

Publications -  18
Citations -  226

Prakash Narayana Reddy is an academic researcher from Vignan University. The author has contributed to research in topics: Antibody & Staphylococcus aureus. The author has an hindex of 5, co-authored 15 publications receiving 159 citations. Previous affiliations of Prakash Narayana Reddy include Defence Food Research Laboratory.

Papers
More filters
Journal ArticleDOI

An Update on Clinical Burden, Diagnostic Tools, and Therapeutic Options of Staphylococcus aureus:

TL;DR: This article has discussed elaborately about the host-pathogen interactions, clinical burden due to S aureus infections, status of diagnostic tools, and treatment options in terms of prophylaxis and therapy.
Journal ArticleDOI

Evaluation of Recombinant Multi-Epitope Outer Membrane Protein-Based Klebsiella pneumoniae Subunit Vaccine in Mouse Model.

TL;DR: Recombinant AK36 protein comprised of immunodominant antigens from outer membrane proteins (Omp’s) of Klebsiella pneumoniae namely OmpA and OmpK36 was highly immunogenic and the hyperimmune sera reacted strongly with native Omp a and OMPK36 proteins from different K. pneumoniae strains.
Journal ArticleDOI

Recombinant pharmaceutical protein production in plants: unraveling the therapeutic potential of molecular pharming

TL;DR: The current status, various strategies and advantages of pharmaceutical protein production in plant expression systems, as well as a summary of expression of therapeutic monoclonal antibodies, vaccines, clinical trials and the regulatory aspects of plant-based expression are presented.
Journal ArticleDOI

Congenital Hypothyroidism: Facts, Facets & Therapy.

TL;DR: Though congenital hypothyroidism is considered as the most common neonatal metabolic disorder, it is also easily treatable compared to other metabolic or hereditary diseases.
Journal ArticleDOI

Recent Advances in Probiotics as Live Biotherapeutics Against Gastrointestinal Diseases.

TL;DR: The causes of gastrointestinal diseases and the present state of various therapeutic strategies such as probiotics as live biotherapeutics and Fecal Microbial Transplants (FMT's) are discussed.